Filtered By:
Therapy: Immunotherapy
Countries: Italy Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 66 results found since Jan 2013.
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study
EClinicalMedicine. 2023 Jun 29;61:102044. doi: 10.1016/j.eclinm.2023.102044. eCollection 2023 Jul.ABSTRACTBACKGROUND: The prospective multicentre observational INVIDIa-2 study investigated the clinical effectiveness of influenza vaccination in patients with advanced cancer receiving immune checkpoint inhibitors (ICI). In this secondary analysis of the original trial, we aimed to assess the outcomes of patients to immunotherapy based on vaccine administration.METHODS: The original study enrolled patients with advanced solid tumours receiving ICI at 82 Italian Oncology Units from Oct 1, 2019, to Jan 31, 2020. The trial's pri...
Source: Cancer Control - July 12, 2023 Category: Cancer & Oncology Authors: Melissa Bersanelli Elena Verzoni Alessio Cortellini Raffaele Giusti Lorenzo Calvetti Paola Ermacora Marilena Di Napoli Annamaria Catino Valentina Guadalupi Giorgia Guaitoli Vieri Scotti Francesca Mazzoni Antonello Veccia Pamela Francesca Guglielmini Fabia Source Type: research
Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy
CONCLUSION: Our findings provided an overview on TT utilization on metastatic melanoma patients in real clinical practice and highlighted an increased burden in brain metastatic patients.PMID:37368101 | DOI:10.1007/s12325-023-02578-y
Source: Adv Data - June 27, 2023 Category: Epidemiology Authors: Ilaria Gioia Marcon Diletta Valsecchi Lorenza Durso Eleonora Premoli Diego Sangiorgi Valentina Perrone Laura Catena Luca Degli Esposti Source Type: research
Allergen-specific immunotherapy and COVID-19: What happened?
CONCLUSIONS: COVID-19 did not seem to influence adherence to SLIT, which declined independently even in during the pre-pandemic 3-year period.PMID:36916100 | DOI:10.15586/aei.v51i2.796
Source: Allergologia et Immunopathologia - March 14, 2023 Category: Allergy & Immunology Authors: Fabiana Furci Bianca Olivieri Laura Benda Federica Robbi Sofia Vallicella Sebastiano Gangemi Gianenrico Senna Marco Caminati Source Type: research
Omalizumab and allergen immunotherapy for respiratory allergies: A mini-review from the Allergen-Immunotherapy Committee of the Italian Society of Pediatric Allergy and Immunology (SIAIP)
Allergol Immunopathol (Madr). 2022 Nov 1;50(6):47-52. doi: 10.15586/aei.v50i6.495. eCollection 2022.ABSTRACTAlthough currently approved to treat severe asthma and chronic spontaneous urticaria, omalizumab has also been an effective and safe add-on treatment for other allergic diseases. Namely, omalizumab has been proposed to be used as add-on therapy in patients with allergic rhinitis and asthma and undergoing specific allergen immunotherapy (AIT). AIT is the only treatment that modifies the natural history of IgE-mediated diseases. This brief review summarizes the available evidence and controversies on the efficacy and s...
Source: Allergologia et Immunopathologia - November 6, 2022 Category: Allergy & Immunology Authors: Maria De Filippo Martina Votto Lucia Caminiti Francesco Carella Giovanna De Castro Massimo Landi Roberta Olcese Ilenia Panasiti Mario Vernich Salvatore Barberi Giorgio Ciprandi Gian Luigi Marseglia Source Type: research
